The 9th Microbiome Movement Drug Development Summit returns in 2024 as North America's definitive microbiome drug development event - and it's back bigger and better than ever!

The microbiome-based therapeutic market is rapidly evolving, and it's more important than ever to showcase the efficacy of microbial-based approaches beyond C. difficile.

Discover how drug developers are advancing their understanding of the role of the microbiome in disease and harnessing functionally relevant microbes for live biotherapeutic approaches.

Join us as we provide in-depth insights into the interactions between the microbiome and metabolic pathways, host-microbe relationships in novel preclinical models, and the application of microbial-based biomarkers in clinical endpoints and diagnostic settings.

Our sessions also cover the mechanistic rationale behind combination therapies, new smart clinical trial data, and GMP-compliant manufacturing for stable products.

With more speakers, content, and networking than ever before, this is set to be the best version of the event yet, and you cannot afford to miss it!

Click here to register